Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Pathologica|March 14, 2024
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labsAngela Santoro, Emma Bragantini, Francesca Castiglione, et al.
Cancer Research|February 19, 2009
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesAndrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosisStefano Signoroni, Milo Frattini, Tiziana Negri, et al.
La Radiologia Medica|March 5, 2022
CT evaluation of lung infiltrates in the two months preceding the Coronavirus disease 19 pandemic in Canton Ticino (Switzerland): were there suspicious cases before the official first case?Stefania Rizzo, Carola Catanese, Carla Puligheddu, et al.
Cancers|January 23, 2024
Antiandrogens as Therapies for COVID-19: A Systematic ReviewMassimiliano Cani, Samantha Epistolio, Giulia Dazio, et al.
Histology and Histopathology|October 15, 2013
EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancerVittoria Martin, Elena Zanellato, Alessandra Franzetti-Pellanda, et al.
Frontiers in Oncology|February 11, 2020
The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT DeregulationFrancesco Marchi, Nora Sahnane, Roberta Cerutti, et al.
Plos One|June 22, 2017
SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutationsAlice Riva, Michael BØrgesen, Mariann Guldmann-Christensen, et al.
Tumori|May 24, 2014
Circulating free DNA in a screening program for early colorectal cancer detectionFederica Perrone, Andrea Lampis, Claudia Bertan, et al.
Plos One|October 7, 2009
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancerAndrea Sartore-Bianchi, Federica Di Nicolantonio, Michele Nichelatti, et al.
Pageof 10